#ALZN
LightNews LightNews
carnivorous.bsky.social
m.youtube.com/watch?v=ALzn...
BABYMETAL - METAL KINGDOM (OFFICIAL)
YouTube video by BABYMETAL
m.youtube.com
June 15, 2025 at 3:46 PM
thinkingmuslim.bsky.social
Our episode with Azzaam Tamimi is out now. Watch here: www.youtube.com/watch?v=ALZN...
Israel is Protected by a Wall of Arab Rulers – Dr Azzam Tamimi
YouTube video by The Thinking Muslim
www.youtube.com
January 11, 2025 at 3:01 PM
saintetienne-loire.ici.fr
Dont deux blessés graves➡️ https://l.ici.fr/Alzn
May 3, 2026 at 8:40 AM
penkeinvesting.bsky.social
I looked at the business behind $ALZN (Alzamend Neuro, Inc.) for you. Based on financial data and reported results.

Read my simple explanation: https://penkeinvesti...

#ALZN
September 20, 2026 at 5:00 PM
smoothstepped.bsky.social
music.youtube.com/watch?v=alzN...
This Man
YouTube video by Common - Topic
music.youtube.com
August 13, 2026 at 11:44 PM
donelll.bsky.social
I'm in heaven.

music.youtube.com/watch?v=alzN...
This Man
YouTube video by Common - Topic
music.youtube.com
September 3, 2025 at 3:52 AM
prismmarketview.bsky.social
#ALZN launches Phase II trial for AL001, a novel Alzheimer’s drug targeting disease modification and symptom relief. With FDA Fast Track status, it aims to address unmet needs for 6M+ patients.
#AlzamendNeuro #Alzheimers #Biotech #ClinicalTrials
Read more: prismmarketview.com/alzamend-neu...
Alzamend Neuro Advances Alzheimer’s Drug Candidate into Phase II Trial
Alzamend Neuro (ALZN) announced the initiation of a Phase II clinical trial for AL001, its lead drug candidate targeting mild to moderate Alzheimer’s disease.
prismmarketview.com
May 13, 2025 at 3:12 PM
marketwirenews.com
News; ( NASDAQ: #ALZN ) Alzamend Neuro Regains Compliance with Nasdaq Listing Standards

#StockMarket #News
October 15, 2024 at 4:15 PM
ici.fr
Municipales : Philippe, 60 ans, retraité, voici le portrait-robot du maire élu à l'issue des élections
➡️ https://l.ici.fr/AlzN
April 30, 2026 at 6:35 AM
strixus.bsky.social
#NightMusic Babymetal - Metal Kingdom music.youtube.com/watch?v=ALzn...
In these passing times,
In this collapsing world,
We are wandering without purpose,
Our hearts lost in the darkness.
We hold on until dawn, moving
Towards that distant light -
We aim for tomorrow.
BABYMETAL - METAL KINGDOM (OFFICIAL)
YouTube video by BABYMETAL
music.youtube.com
October 27, 2025 at 5:03 AM
strixus.bsky.social
#NightMusic Babymetal - Metal Kingdom
music.youtube.com/watch?v=ALzn...
Rise up KINGDOM,
Unleash FREEDOM.
An endless journey, a dream without end.
Wake up, KINGDOM
Take hold of your FREEDOM
Now is the time of dawn
To bathe us in the light.
So cut through the darkness.
BABYMETAL - METAL KINGDOM (OFFICIAL)
YouTube video by BABYMETAL
music.youtube.com
July 12, 2025 at 4:06 AM
spacedlaw.bsky.social
a man in a suit and tie is sitting in a chair .
Alt: Alzn Rickmanas a man in a suit and tie sitting in a chair, making some approval gesture with his head.
media.tenor.com
February 24, 2025 at 11:17 AM
stocktitan.net
#ALZN Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of Alzheimer’s Disease to take Place at Massachusetts General Hospital

https://www.stocktitan.net/news/ALZN/alzamend-neuro-announces-initiation-date-of-phase-ii-clinical-trial-sk1gkwkfm1fn.html
Major Breakthrough: New Alzheimer's Drug Advances to Phase II at Top Hospital
Advanced lithium-based treatment shows superior brain absorption with reduced side effects. Phase II trial at Mass General to validate breakthrough approach. Full analysis inside.
www.stocktitan.net
March 25, 2025 at 12:00 PM
marketwirenews.com
News; ( NASDAQ: #ALZN ) Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next-Generation Lithium Therapeutic Drug Candidate, involving Patients with Alzheimer's Disease

#StockMarket #News
August 5, 2024 at 3:05 PM
biopharmcatalyst.bsky.social
$HCWB reported that HCW9206 fusion protein demonstrated superior preclinical results in CAR-T manufacturing at AAI 2025.

See More Biotech Updates👇
www.biopharmcatalyst.com/news/2025/hc...

$HCWB $AFMD $HUMA $CNSP $APYX $SGMO $ALZN $ALUR
May 13, 2025 at 8:55 PM
marketwirenews.com
NEWS: ( NASDAQ: #ALZN ) Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next?Generation Lithium Therapeutic Drug Candidate, involving Patients with Major Depressive Disorder

#StockMarket #News
August 12, 2024 at 3:30 PM
biopharmcatalyst.bsky.social
$AXDX voluntarily filed for Chapter 11 bankruptcy in Delaware and will pursue a court-supervised sale of its assets.

See More Biotech Updates👇
www.biopharmcatalyst.com/news/2025/vo...

$CRVS $VOR $ALZN $AXDX $EBS $ECOR $XGN $ALVO $ZVSA $NVAX
May 8, 2025 at 8:39 PM
marketwirenews.com
BREAKING NEWS: ( NASDAQ: #ALZN ) Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next?Generation Lithium Therapeutic Drug Candidate, involving Patients with Post-Traumatic Stress Disorder

#StockMarket #News
August 19, 2024 at 2:10 PM
biopharmcatalyst.bsky.social
$ALZN dosed the first subject in its Phase II “Lithium‑in‑Brain” study comparing AL001 to lithium carbonate; topline data are expected by year‑end  2025.

See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2025/al...

$IMNN $NTLA $ORIC $REVB $TSHA $COCP $TIL
May 29, 2025 at 12:37 PM
smcapstrategist.bsky.social
Small-cap stocks with strong volume declines, Wed May 7th - #WRD #SYTA #OKYO #KAVL #SNCR #MYGN #LFVN #HAIN #GDRX #YAAS #ARIS #BGS #EPC #GFR #MAGN #RVLV #VSTS #ALZN #BNR #CEVA - More: crystalequityresearch.com/SmCpStr/ - #smallcap
SmCpStr Technicals – Technical Indicators for Small-cap Stocks
crystalequityresearch.com
May 8, 2025 at 1:37 AM
biopharmcatalyst.bsky.social
$REVB priced a $4 million public offering of 3.64 million shares (or equivalents) and warrants for up to 14.56 million shares at $1.10 per share and warrant.

See More Biotech Updates👇
www.biopharmcatalyst.com/news/2025/al...

$ALZN $REVB $IMNN $INTS $ORIC $IMUX $NTLA $APDN
May 29, 2025 at 8:41 PM
penkeinvesting.bsky.social
I looked at the business behind $ALZN (Alzamend Neuro, Inc.) for you. Based on financial data and reported results.

Read my simple explanation: https://penkeinvesti...

#ALZN
September 16, 2026 at 4:12 PM
stocktitan.net
#ALZN Alzamend Neuro Regains Compliance with Nasdaq Listing Standards

https://www.stocktitan.net/news/ALZN/alzamend-neuro-regains-compliance-with-nasdaq-listing-gt6vw80icru7.html?utm_source=stocktitan-bluesky&utm_medium=social
Alzamend Neuro Regains Compliance with Nasdaq Listing Standards
Stock Titan provides an ultra-fast stock market news feed and multiple tools for traders and investors.
www.stocktitan.net
September 16, 2026 at 12:00 PM
newsen.bsky.social
Alzamend Neuro Achieves Compliance with Nasdaq Requirements - A New Chapter in Biopharmaceuticals#USA#NASDAQ#Atlanta#Alzamend_Neuro#ALZN
Alzamend Neuro Achieves Compliance with Nasdaq Requirements - A New Chapter in Biopharmaceuticals
Alzamend Neuro has successfully met Nasdaq's listing requirements, marking a significant milestone for the biopharmaceutical company as it focuses on developing treatments for mental health disorders.
third-news.com
September 16, 2026 at 12:15 PM
prismmarketview.bsky.social
Alzamend Neuro (#$ALZN) regains Nasdaq compliance, reporting $5.8M in stockholders' equity, well above the $2.5M minimum. Clears delisting risk. Company now focuses on AL001's four Phase II trials with Mass General, starting with a bipolar disorder cohort.

prismmarketview.com/alzamend-neu...
Alzamend Neuro Regains Nasdaq Compliance After Exceeding Equity Requirement
Key Points Alzamend Neuro has regained compliance with Nasdaq’s continued-listing requirements. The company reported stockholders’ equity of approxi
prismmarketview.com
September 16, 2026 at 2:14 PM